Rhythm

HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board

SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a U.S.-based medical device company that is leading innovation in the field of electrocardiology through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced today that Peter W. Macfarlane has joined its board of clinical advisors. Professor Peter W. Macfarlane, DSc eFESC FRSE, […]

New Study Examines Online Vs Offline ECG Monitoring to Detect Difficult-to-Diagnose Arrhythmia

BOSTON, May 2, 2018 /PRNewswire/ — Medicalgorithmics, S.A. (WSE: MDG) today announced the presentation of a large study evaluating online vs offline ECG monitoring methods to diagnose paroxysmal atrial fibrillation (AF), often difficult to detect because of its episodic nature. Research will be presented at the Heart Rhythm Society Annual Scientific Sessions, May 9-12 at […]

LuxCath to Showcase Its Breakthrough OmniView Light-Guided Ablation Catheter at HRS 2018

BOSTON–(BUSINESS WIRE)–LuxCath, LLC will showcase the next generation of its proprietary OmniView™ light-guided catheter ablation system at the 2018 Heart Rhythm Society (HRS) conference in Boston, May 9 to 12 at the Boston Convention Center. The OmniView light-guided ablation catheter is the only technology that can see into tissue during cardiac […]

LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million

LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]

BioSig Technologies to Partner with High Lantern Group

Santa Monica, CA, April 26, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has appointed High Lantern Group (HLG) to assist in building a global stakeholder engagement strategy as the […]

ams Introduces Sensor Reference Design for Blood Pressure, Vital Signs for Smart Health and Wearables

PREMSTAETTEN, Austria–(BUSINESS WIRE)–ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, today announced the release of the first integrated vital sign sensor reference design based on its AS7024. The solution can perform accurate, fast and convenient 24/7 cuffless blood pressure measurement. The new vital signs sensor reference […]

The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025

LONDON, April 23, 2018 /PRNewswire/ — Microelectronic Medical Implants Market Analysis Report by Product (Pacemakers & Defibrillators, Neurostimulators, Implantable Drug Pumps, Spinal Fusion Stimulators), by Technology, And Segment Forecasts, 2018 – 2025 Download the full report: https://www.reportbuyer.com/product/5360535 The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025, according to […]

VGS Initiates U.S. Pivotal Trial to Evaluate the Use of Its VEST Technology for Bypass Surgery

TEL AVIV, Israel, April 23, 2018 /PRNewswire/ — Vascular Graft Solutions Ltd (VGS) announces on enrollment of the first 20 patients into the VEST US pivotal trial that will evaluate the safety and effectiveness of the VEST, a novel external support device for treatment of saphenous vein graft disease after coronary artery […]

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

BROOMFIELD, Colo.–(BUSINESS WIRE)–ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc. (NYSE:MDT), a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA’s proposed […]

Tinton Falls Company Gets FDA Approval For Early Heart Attack Detection Device

Angel Medical Systems, Inc. of Tinton Falls announced that they have received FDA pre-market approval on a medical device that detects heart attacks before patients experience symptoms. The AngelMed Guardian System is an implantable heart monitor with internal and external alerting capabilities to urge at-risk patients with pre-existing cardiac conditions […]